Genzyme Corp., a Cambridge biotechnology company, has signed a seven-year lease for 114,000 square feet of space at an office building in Westborough. Later this year, it plans to relocate operations from a satellite office in Framingham, Ferris Development Group said.

The 283,000-square-foot building at One Research Drive was bought in November by 25 clients of Ferris Capital LLC, along with seven other investors for $21.5 million.

At the time, the building was 50 percent vacant. With the Genzyme lease, it will have 93 percent occupancy, Ferris Development said.

Using its in-house construction team, Ferris Development embarked on significant renovations to the building, it said. They included a new lobby and a new stone facade entrance, along with the creation of a patio.


Genzyme is based in Cambridge but has a big presence in Framingham, including a research-and-development center and several manufacturing facilities, said David Murdoch, the company's director of communications for industrial operations.

Genzyme has decided to relocate to Westborough about 500 Framingham employees who work in such jobs as informational services and quality control.

The lease on the office building where they currently work is expiring, and the Westborough building offered lower rents and better amenities, Murdoch said.

Genzyme's R&D center and manufacturing facilities will remain in Framingham, he said.

Chris Reidy can be reached at reidy@globe.com.